BioSpace News Archive

Drug Development

Novartis Published Multiple Sclerosis Trial Data With Plans to File for FDA Approval

Novartis released full results from its Phase III EXPAND trial of siponimod (BAF312) in secondary progressive multiple sclerosis (SPMS), which it published in the journal The Lancet.

March 23, 2018
·
2 min read
·
Mark Terry
German Biotech MorphoSys Seeks Nasdaq Listing

MorphoSys, a Germany-based biopharmaceutical company, is aiming for a listing on the Nasdaq exchange hoping to secure approximately $150 million.

March 23, 2018
·
2 min read
·
Alex Keown
Deals

Akebia Announces $85M Public Offering

Akebia Therapeutics, a kidney disease company, announced plans to offer and sell about $85 million of its common stock in an underwritten public offering.

March 23, 2018
·
2 min read
·
Mark Terry
Deals

GSK Walks Away From Acquiring Pfizer Consumer Goods Unit

GlaxoSmithKline has decided not to make a play for Pfizer’s consumer health business. The decision came one day after another potential suitor walked away from a potential deal.

March 23, 2018
·
2 min read
·
Alex Keown
Job Trends

Pharma Execs are Attractive Candidates for Healthcare Leadership Roles

Healthcare companies are now looking at pharma executives for leadership roles as the landscape of healthcare is dramatically changing.

March 23, 2018
·
2 min read
·
Alex Keown
Job Trends

Caris Life Sciences Announces Published Results Showing that its ADAPT Biotargeting System Effectively Stratified Breast Cancer Patients Based on Their Benefit from Trastuzumab Treatment (Herceptin)

Data featured in Nature Communications showed ADAPT Biotargeting System significantly out-performed industry standard HER2 testing

March 23, 2018
·
4 min read
Job Trends

HER Foundation Helps UCLA, USC and 23&Me Link Debilitating Pregnancy Illness to Two Genes

A breakthrough for women suffering from the severe pregnancy illness Hyperemesis Gravidarum.

March 23, 2018
·
3 min read
Biotech Beach

Male Birth Control Pill Shows Promise

A breakthrough in oral male contraception, researchers show feasibility of “the pill” for men.

March 23, 2018
·
2 min read
FDA

Auris Health Unveils the FDA-Cleared Monarch Platform, Ushering in a New Era of Medical Intervention

Company’s First Application of Its Innovative Flexible Robotics Platform Is Bronchoscopy

March 23, 2018
·
4 min read
Pharm Country

Data Shows That the Global Addiction Treatment Market is Set to Grow

Data provided by Transparency Market Research, indicates that global addiction treatment market was valued at approximately US$ 4.0 billion in 2016 and is anticipated to expand at a CAGR of over 6.0% from 2017 to 2025 or reaching value of approximately US$ 7.0 billion by 2025.

March 23, 2018
·
10 min read